America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...
On a spring day this year, the New Jersey State Policemen’s Benevolent Association received three unusual visitors: ...
Weight-loss drug makers are directly targeting employers in a campaign to expand health insurance coverage of their popular, ...
At the end of 2023, I had gained 37 pounds. So, my doctor and I decided to try Zepbound (tirzepatide), a weight loss ...
The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...
Drug manufacturers are racing to develop an oral version of popular weight loss injectables like Ozempic, and early studies ...
Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...
A survey by consulting firm Mercer shows that close to half of U.S. companies with more than 500 employees now cover drugs ...
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...
Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback